Design of novel DABO derivatives as HIV-1 RT inhibitors using molecular docking, molecular dynamics simulations and ADMET properties

References

• Abdi, H., & Williams, L. J. (2013). Comparative Molecular Similarity Index Analysis (CoMSIA) to study hydrogen-bonding properties and to score combinatorial libraries. Methods in Molecular Biology, 930, 549–579.
   PubMedGoogle Scholar
• Baba, M., Tanaka, H., De Clercq, E., Pauwels, R., Balzarini, J., Schols, D., Nakashima, H., Perno, C. F., Walker, R. T., & Miyasaka, T. (1989). Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative. Biochemical and Biophysical Research Communications, 165(3), 1375–1381. https://doi.org/10.1016/0006-291x(89)92756-3
   PubMed Web of Science ®Google Scholar
• Berendsen, H. J. C., van der Spoel, D., & van Drunen, R. (1995). GROMACS: A message-passing parallel molecular dynamics implementation. Computer Physics Communications, 91(1–3), 43–56. https://doi.org/10.1016/0010-4655(95)00042-E
   Web of Science ®Google Scholar
• Brito, M. A. d., Rodrigues, C. R., Cirino, J. J. V., de Alencastro, R. B., Castro, H. C., & Albuquerque, M. G. (2008). 3D-QSAR CoMFA of a Series of DABO derivatives as HIV-1 reverse transcriptase non-nucleoside inhibitors. Journal of Chemical Information and Modeling, 48(8), 1706–1715. https://doi.org/10.1021/ci8001217
   PubMed Web of Science ®Google Scholar
• Case, D. A., Cheatham, T. E., 3rd, Darden, T., Gohlke, H., Luo, R., Merz, K. M., Jr., Onufriev, A., Simmerling, C., Wang, B., & Woods, R. J. (2005). The Amber biomolecular simulation programs. Journal of Computational Chemistry, 26(16), 1668–1688. https://doi.org/10.1002/jcc.20290
   PubMed Web of Science ®Google Scholar
• Chen, L., Liu, W. G., Xiong, F., Ma, C., Sun, C., Zhu, Y. R., Zhang, X. G., & Wang, Z.-H. (2021). 3D-QSAR, molecular docking and molecular dynamics simulations analyses of a series of heteroaryldihydropyrimidine derivatives as hepatitis B virus capsid assembly inhibitors. New Journal of Chemistry, 45(47), 22062–22076. https://doi.org/10.1039/D1NJ02542B
   Web of Science ®Google Scholar
• Clark, R. D., & Fox, P. C. (2004). Statistical variation in progressive scrambling. Journal of Computer-Aided Molecular Design, 18(7-9), 563–576. https://doi.org/10.1007/s10822-004-4077-z
   PubMed Web of Science ®Google Scholar
• Cramer, R. D., Patterson, D. E., & Bunce, J. D. (1988). Comparative Molecular Field Analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. Journal of the American Chemical Society, 110(18), 5959–5967. https://doi.org/10.1021/ja00226a005
   PubMed Web of Science ®Google Scholar
• Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717. https://doi.org/10.1038/srep42717
   PubMed Web of Science ®Google Scholar
• D'Cruz, O. J., & Uckun, F. M. (2006). Novel tight binding PETT, HEPT and DABO-based non-nucleoside inhibitors of HIV-1 reverse transcriptase. Journal of Enzyme Inhibition and Medicinal Chemistry, 21(4), 329–350. https://doi.org/10.1080/14756360600774413
   PubMed Web of Science ®Google Scholar
• de Bethune, M. P. (2010). Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989-2009). Antiviral Research, 85(1), 75–90. https://doi.org/10.1016/j.antiviral.2009.09.008
   PubMed Web of Science ®Google Scholar
• de Brito, M. A., Rodrigues, C. R., Cirino, J. J., Araujo, J. Q., Honorio, T., Cabral, L. M., de Alencastro, R. B., Castro, H. C., & Albuquerque, M. G. (2012). Residue-ligand interaction energy (ReLIE) on a receptor-dependent 3D-QSAR analysis of S- and NH-DABOs as non-nucleoside reverse transcriptase inhibitors. Molecules 17, 7666–7694. https://doi.org/10.3390/molecules17077666
   PubMed Web of Science ®Google Scholar
• De Clercq, E. (2019). Fifty years in search of selective antiviral drugs. Journal of Medicinal Chemistry, 62(16), 7322–7339. https://doi.org/10.1021/acs.jmedchem.9b00175
   PubMed Web of Science ®Google Scholar
• Dong, M., & Ren, Y. (2015). Molecular modeling studies of dihydro-alkyloxybenzyl-oxopyrimidines (DABOs) as non-nucleoside inhibitors of HIV-1 reverse transcriptase using 3D-QSAR, Topomer CoMFA and molecular docking simulations. RSC Advances, 5(18), 13754–13761. https://doi.org/10.1039/C4RA15397A
   Web of Science ®Google Scholar
• Elliott, D., Johnston, B. M., & Johnston, P. R. (2016). The method of steepest descent for estimating quadrature errors. The Journal of Computational and Applied Mathematics, 303, 93–104. https://doi.org/10.1016/j.cam.2016.02.028
   Web of Science ®Google Scholar
• Ferreira, L. L. G., & Andricopulo, A. D. (2019). ADMET modeling approaches in drug discovery. Drug Discovery Today, 24(5), 1157–1165. https://doi.org/10.1016/j.drudis.2019.03.015
   PubMed Web of Science ®Google Scholar
• Fu, L., Chen, Y., Xu, C. M., Wu, T., Guo, H. M., Lin, Z. H., Wang, R., & Shu, M. (2020). 3D-QSAR, HQSAR, molecular docking, and new compound design study of 1,3,6-trisubstituted 1,4-diazepan-7-ones as human KLK7 inhibitors. Medicinal Chemistry Research, 29(6), 1012–1029. https://doi.org/10.1007/s00044-020-02542-3
   Web of Science ®Google Scholar
• Gomes, R. A., Genesi, G. L., Maltarollo, V. G., & Trossini, G. H. G. (2017). Quantitative structure-activity relationships (HQSAR, CoMFA, and CoMSIA) studies for COX-2 selective inhibitors. Journal of Biomolecular Structure and Dynamics, 35, 1436–1445. https://doi.org/10.1080/07391102.2016.1185379
   PubMed Web of Science ®Google Scholar
• Han, S., Lei, Y., Pannecouque, C., De Clercq, E., Zhuang, C. L., & Chen, F. E. (2020). Fragment-based discovery of sulfur-containing diarylbenzopyrimidines as novel nonnucleoside reverse transcriptase inhibitors. Chinese Chemical Letters, 31(3), 764–768. https://doi.org/10.1016/j.cclet.2019.11.020
   Web of Science ®Google Scholar
• He, Y., Chen, F., Sun, G., Wang, Y., De Clercq, E., Balzarini, J., & Pannecouque, C. (2004). 5-Alkyl-2-[(aryl and alkyloxylcarbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-ones as an unique HIV reverse transcriptase inhibitors of S-DABO series. Bioorganic & Medicinal Chemistry Letters, 14(12), 3173–3176. https://doi.org/10.1016/j.bmcl.2004.04.008
   PubMed Web of Science ®Google Scholar
• He, Y. P., Long, J., Zhang, S. S., Li, C., Lai, C. C., Zhang, C. S., Li, D. X., Zhang, D. H., Wang, H., Cai, Q. Q., & Zheng, Y. T. (2011). Synthesis and biological evaluation of novel dihydro-aryl/alkylsulfanyl-cyclohexylmethyl-oxopyrimidines (S-DACOs) as high active anti-HIV agents. Bioorganic & Medicinal Chemistry Letters, 21(2), 694–697. https://doi.org/10.1016/j.bmcl.2010.12.003
   PubMed Web of Science ®Google Scholar
• Huang, B., Chen, W., Zhao, T., Li, Z., Jiang, X., Ginex, T., Vilchez, D., Luque, F. J., Kang, D., Gao, P., Zhang, J., Tian, Y., Daelemans, D., De Clercq, E., Pannecouque, C., Zhan, P., & Liu, X. (2019). Exploiting the tolerant region i of the non-nucleoside reverse transcriptase inhibitor (NNRTI) binding pocket: Discovery of potent diarylpyrimidine-typed HIV-1 NNRTIs against wild-type and E138K mutant virus with significantly improved water solubility and favorable safety profiles. Journal of Medicinal Chemistry, 62(4), 2083–2098. https://doi.org/10.1021/acs.jmedchem.8b01729
   PubMed Web of Science ®Google Scholar
• Isegawa, M., & Kato, S. (2009). Polarizable force field for protein with charge response kernel. Journal of Chemical Theory and Computation, 5, 2809–2821. https://doi.org/10.1021/ct900295u
   PubMed Web of Science ®Google Scholar
• James, J. P., Ishwar Bhat, K., More, U. A., & Joshi, S. D. (2018). Design, synthesis, molecular modeling, and ADMET studies of some pyrazoline derivatives as shikimate kinase inhibitors. Medicinal Chemistry Research, 27(2), 546–559. https://doi.org/10.1007/s00044-017-2081-9
   Web of Science ®Google Scholar
• Jayatilleke, P. R. N., Nair, A. C., Zauhar, R., & Welsh, W. J. (2000). Computational studies on HIV-1 protease inhibitors: Influence of calculated inhibitor-enzyme binding affinities on the statistical quality of 3D-QSAR CoMFA models. Journal of Medicinal Chemistry, 43(23), 4446–4451. https://doi.org/10.1021/jm9905357
   PubMed Web of Science ®Google Scholar
• Jonniya, N. A., Sk, M. F., & Kar, P. (2019). Investigating phosphorylation-induced conformational changes in WNK1 kinase by molecular dynamics simulations. ACS Omega, 4, 17404–17416. https://doi.org/10.1021/acsomega.9b02187
   PubMed Web of Science ®Google Scholar
• Kang, D., Zhang, H., Wang, Z., Zhao, T., Ginex, T., Luque, F. J., Yang, Y., Wu, G., Feng, D., Wei, F., Zhang, J., De Clercq, E., Pannecouque, C., Chen, C. H., Lee, K. H., Murugan, N. A., Steitz, T. A., Zhan, P., & Liu, X. (2019). Identification of Dihydrofuro[3,4-d]pyrimidine derivatives as novel HIV-1 non-nucleoside reverse transcriptase inhibitors with promising antiviral activities and desirable physicochemical properties. Journal of Medicinal Chemistry, 62(3), 1484–1501. https://doi.org/10.1021/acs.jmedchem.8b01656
   PubMed Web of Science ®Google Scholar
• Khaldan, A., Bouamrane, S., El-Mernissi, R., Alaqarbeh, M., Hajji, H., Alsakhen, N., Maghat, H., Ajana, M. A., Sbai, A., Bouachrine, M., & Lakhlifi, T. (2022). Computational study of quinoline-based thiadiazole compounds as potential antileishmanial inhibitors. New Journal of Chemistry, 46(36), 17554–17576. https://doi.org/10.1039/D2NJ03253H
   Web of Science ®Google Scholar
• Klebe, G., Abraham, U., & Mietzner, T. (1994). Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. Journal of Medicinal Chemistry, 37(24), 4130–4146. https://doi.org/10.1021/jm00050a010
   PubMed Web of Science ®Google Scholar
• Ling, X., Hao, Q. Q., Pannecouque, C., Clercq, E., & Chen, F. E. (2022). Expansion of the S–CN-DABO scaffold to exploit the impact on inhibitory activities against the non-nucleoside HIV-1 reverse transcriptase. European Journal of Medicinal Chemistry, 238, 114512. https://doi.org/10.1016/j.ejmech.2022.114512
   PubMed Web of Science ®Google Scholar
• Liu, W. G., Hong, D. F., Xi, C. C., Ma, C., Xiong, F., & Zhang, S. P. (2020). 3D-QSAR analysis of a series of dihydroquinolizinone derivatives as a hepatitis B virus expression inhibitor. Chinese Journal of Structural Chemistry, 39, 1615–1626.
   Web of Science ®Google Scholar
• Ma, C., Liu, W. G., Liu, W. D., Xi, C. C., Xiong, F., & Zhang, S. P. (2022). Molecular docking and 3D-QSAR studies on a series of benzenesulfonamide derivatives as a Hepatitis B virus capsid assembly inhibitor. Polycyclic Aromatic Compounds, 42(6), 3622–3637. https://doi.org/10.1080/10406638.2020.1871038
   Web of Science ®Google Scholar
• Maddah, M., Bahramsoltani, R., Yekta, N. H., Rahimi, R., Aliabadi, R., & Pourfath, M. (2021). Proposing high-affinity inhibitors from Glycyrrhiza glabra L. against SARS-CoV-2 infection: Virtual screening and computational analysis. New Journal of Chemistry, 45(35), 15977–15995. https://doi.org/10.1039/D1NJ02031E
   Web of Science ®Google Scholar
• Mao, Y., Li, Y., Hao, M., Zhang, S., & Ai, C. (2012). Docking, molecular dynamics and quantitative structure-activity relationship studies for HEPTs and DABOs as HIV-1 reverse transcriptase inhibitors. Journal of Molecular Modeling, 18(5), 2185–2198. https://doi.org/10.1007/s00894-011-1236-8
   PubMed Web of Science ®Google Scholar
• Miller, B. R., 3rd, McGee, T. D., Jr., Swails, J. M., Homeyer, N., Gohlke, H., & Roitberg, A. E. (2012). MMPBSA.py: An efficient program for end-state free energy calculations. Journal of Chemical Theory and Computation, 8(9), 3314–3321. https://doi.org/10.1021/ct300418h
   PubMed Web of Science ®Google Scholar
• Miyasaka, T., Tanaka, H., Baba, M., Hayakawa, H., Walker, R. T., Balzarini, J., & De Clercq, E. (1989). A novel lead for specific anti-HIV-1 agents: L -[(2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine. Journal of Medicinal Chemistry, 32(12), 2507–2509. https://doi.org/10.1021/jm00132a002
   PubMed Web of Science ®Google Scholar
• Muniz, L. S., & da Rocha Pita, S. S. (2022). In silico studies revealed interaction mechanisms of benzylidene-acrylohydrazide derivatives and nsP2 CHIKV. New Journal of Chemistry, 46(14), 6414–6423. https://doi.org/10.1039/D1NJ05593C
   Web of Science ®Google Scholar
• Nawrozkij, M. B., Forgione, M., Yablokov, A. S., Lucidi, A., Tomaselli, D., Patsilinakos, A., Panella, C., Hailu, G. S., Kirillov, I. A., Badia, R., Riveira-Munoz, E., Crespan, E., Armijos Rivera, J. I., Cirilli, R., Ragno, R., Este, J. A., Maga, G., Mai, A., & Rotili, D. (2019). Effect of α-methoxy substitution on the anti-HIV activity of dihydropyrimidin-4(3H)-ones. Journal of Medicinal Chemistry, 62(2), 604–621. https://doi.org/10.1021/acs.jmedchem.8b01238
   PubMed Web of Science ®Google Scholar
• Pires, D. E., Blundell, T. L., & Ascher, D. B. (2015). pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry, 58(9), 4066–4072. https://doi.org/10.1021/acs.jmedchem.5b00104
   PubMed Web of Science ®Google Scholar
• Pourbasheer, E., & Aalizadeh, R. (2016). 3D-QSAR and molecular docking study of LRRK2 kinase inhibitors by CoMFA and CoMSIA methods. SAR and QSAR in Environmental Research, 27(5), 385–407. https://doi.org/10.1080/1062936X.2016.1184713
   PubMed Web of Science ®Google Scholar
• Rigsby, R. E., & Parker, A. B. (2016). Using the PyMOL application to reinforce visual understanding of protein structure. Biochemistry and Molecular Biology Education, 44, 433–437. https://doi.org/10.1002/bmb.20966
   PubMed Web of Science ®Google Scholar
• Roy, K. (2007). On some aspects of validation of predictive quantitative structure–activity relationship models. Expert Opinion on Drug Discovery, 2(12), 1567–1577. https://doi.org/10.1517/17460441.2.12.1567
   PubMed Web of Science ®Google Scholar
• Rui, R. M., Tang, C. R., Zhang, C. T., Pan, W. K., Gan, K., Luo, R. H., Wei, Z. Q., Jing, F. S., Huang, S. M., Yang, L. M., Li, Y. M., Wang, Y. P., Xiao, W. L., Zhang, H. B., Zheng, Y. T., & He, Y. P. (2022). C6-structural optimizations of 2-aryl-1H-pyrazole-S-DABOs: From anti-HIV to anti-DENV activity. Bioorganic Chemistry, 119, 105494. https://doi.org/10.1016/j.bioorg.2021.105494
   PubMed Web of Science ®Google Scholar
• Tuo, Y., Li, G., Liu, Z., Yu, N., Li, Y., Yang, L., Liu, H., & Wang, Y. (2022). Discovery of novel antifungal resorcylate aminopyrazole Hsp90 inhibitors based on structural optimization by molecular simulations. New Journal of Chemistry, 46(10), 4890–4899. https://doi.org/10.1039/D1NJ04927E
   Web of Science ®Google Scholar
• Valdes-Tresanco, M. S., Valdes-Tresanco, M. E., Valiente, P. A., & Moreno, E. (2021). gmx_MMPBSA: A new tool to perform end-state free energy calculations with GROMACS. Journal of Chemical Theory and Computation, 17(10), 6281–6291. https://doi.org/10.1021/acs.jctc.1c00645
   PubMed Web of Science ®Google Scholar
• Van Der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., & Berendsen, H. J. (2005). GROMACS: Fast, flexible, and free. Journal of Computational Chemistry, 26(16), 1701–1718. https://doi.org/10.1002/jcc.20291
   PubMed Web of Science ®Google Scholar
• Wang, Y., Chang, J., Wang, J., Zhong, P., Zhang, Y., Lai, C. C., & He, Y. (2019). 3D-QSAR Studies of S-DABO derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors. Letters in Drug Design & Discovery, 16(8), 868–881. https://doi.org/10.2174/1570180815666180810112321
   Web of Science ®Google Scholar
• Wu, Y., Tang, C., Rui, R., Yang, L., Ding, W., Wang, J., Li, Y., Lai, C. C., Wang, Y., Luo, R., Xiao, W., Zhang, H., Zheng, Y., & He, Y. (2020). Synthesis and biological evaluation of a series of 2-(((5-akly/aryl-1H-pyrazol-3-yl)methyl)thio)-5-alkyl-6-(cyclohexylmethyl)-pyrimidin-4(3H)- ones as potential HIV-1 inhibitors. Acta Pharmaceutica Sinica. B, 10(3), 512–528. https://doi.org/10.1016/j.apsb.2019.08.009
   PubMed Web of Science ®Google Scholar
• Xiong, F., Chen, L., Zhang, Y. J., Zhu, Y. R., Sun, C., Ma, C., Zhang, S. J., & Wang, Z. H. (2022). Molecular modeling and docking studies of 2,4,5-trisubstituted pyrimidines as HIV-1 non-nucleoside reverse transcriptase inhibitors. Polycyclic Aromatic Compounds. https://doi.org/10.1080/10406638.2022.2141274
   Web of Science ®Google Scholar
• Xu, H. R., Fu, L., Zhan, P., & Liu, X. Y. (2016). 3D-QSAR analysis of a series of S-DABO derivatives as anti-HIV agents by CoMFA and CoMSIA. SAR and QSAR in Environmental Research, 27(12), 999–1014. https://doi.org/10.1080/1062936X.2016.1233580
   PubMed Web of Science ®Google Scholar
• Yuan, S., Chan, H. C. S., & Hu, Z. (2017). Using PyMOL as a platform for computational drug design. WIREs Computational Molecular Science, 7(2), e1298.
   Google Scholar
• Zhang, Y. J., Chen, L., Xu, J., Jiang, H. F., Zhu, Y. R., Wang, Z. H., & Xiong, F. (2022). Evaluation of novel HIV-1 protease inhibitors with DRV-resistance by utilizing 3D-QSAR molecular docking and molecular dynamics simulation. New Journal of Chemistry, 46(45), 21885–21897. https://doi.org/10.1039/D2NJ04492G
   Web of Science ®Google Scholar
• Zhao, Y., Li, W., Li, W., Tao, H., Li, Y., Wu, B., Wang, X., Zhou, H., & Gao, B. (2022). Novel target study to cure cardiovascular disease regarding proprotein converse subtilisin/kexin type 9. BioMed Research International, 2022, 9039377. https://doi.org/10.1155/2022/9039377
   PubMed Web of Science ®Google Scholar
• Zhou, Z., Hu, T., Zhou, X., Wildum, S., Garcia-Alcalde, F., Xu, Z., Wu, D., Mao, Y., Tian, X., Zhou, Y., Shen, F., Zhang, Z., Tang, G., Najera, I., Yang, G., Shen, H. C., Young, J. A., & Qin, N. (2017). Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) inhibit hepatitis B virus replication by different molecular mechanisms. Scientific Reports, 7, 42374. https://doi.org/10.1038/srep42374
   PubMed Web of Science ®Google Scholar
• Zhou, Z., Liu, T., Kang, D., Huo, Z., Wu, G., Daelemans, D., De Clercq, E., Pannecouque, C., Zhan, P., & Liu, X. (2018). Discovery of novel diarylpyrimidines as potent HIV-1 NNRTIs by investigating the chemical space of a less explored “hydrophobic channel. Organic & Biomolecular Chemistry, 16(6), 1014–1028. https://doi.org/10.1039/c7ob02828h
   PubMed Web of Science ®Google Scholar
• Zhuang, C., Pannecouque, C., De Clercq, E., & Chen, F. (2020). Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): our past twenty years. Acta Pharmaceutica Sinica. B, 10(6), 961–978. https://doi.org/10.1016/j.apsb.2019.11.010
   PubMed Web of Science ®Google Scholar